These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11987906)

  • 1. Treatment of central precocious puberty.
    Partsch CJ; Sippell WG
    Best Pract Res Clin Endocrinol Metab; 2002 Mar; 16(1):165-89. PubMed ID: 11987906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-acting GnRH analogue triptorelin therapy in central isosexual precocious puberty.
    Bajpai A; Sharma J; Kabra M; Gupta AK; Menon PS
    Indian Pediatr; 2002 Jul; 39(7):633-9. PubMed ID: 12147888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precocious puberty and statural growth.
    Carel JC; Lahlou N; Roger M; Chaussain JL
    Hum Reprod Update; 2004; 10(2):135-47. PubMed ID: 15073143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
    Paterson WF; McNeill E; Young D; Donaldson MD
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin changes in Taiwanese girls with central precocious puberty before and during the GnRH agonist treatment.
    Su PH; Wang SL; Lin CY; Chen JY; Changlai CP; Jian SH; Chen SJ
    Acta Paediatr Taiwan; 2005; 46(5):278-83. PubMed ID: 16640001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of three doses of leuprolide acetate in the treatment of central precocious puberty: preliminary results.
    Mericq V; Lammoglia JJ; Unanue N; Villaroel C; Hernández MI; Avila A; Iñiguez G; Klein KO
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):686-90. PubMed ID: 19302581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early puberty in girls.
    Mul D; Oostdijk W; Drop SL
    Best Pract Res Clin Endocrinol Metab; 2002 Mar; 16(1):153-63. PubMed ID: 11987905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consensus statement on the use of gonadotropin-releasing hormone analogs in children.
    Carel JC; Eugster EA; Rogol A; Ghizzoni L; Palmert MR; ; Antoniazzi F; Berenbaum S; Bourguignon JP; Chrousos GP; Coste J; Deal S; de Vries L; Foster C; Heger S; Holland J; Jahnukainen K; Juul A; Kaplowitz P; Lahlou N; Lee MM; Lee P; Merke DP; Neely EK; Oostdijk W; Phillip M; Rosenfield RL; Shulman D; Styne D; Tauber M; Wit JM
    Pediatrics; 2009 Apr; 123(4):e752-62. PubMed ID: 19332438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of central precocious puberty by GnRH analogs: long-term outcome in men.
    Bertelloni S; Mul D
    Asian J Androl; 2008 Jul; 10(4):525-34. PubMed ID: 18478155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Final adult height in "early normal pubertal girls" treated with gonadotropin releasing hormone agonists.
    Wacharasindhu S; Srivuthana S; Aroonparkmongkol S; Supornsilchai V; Hiranrat P; Yodvisitsak V
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S170-3. PubMed ID: 12929985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central precocious puberty in a girl with Williams syndrome: the result of treatment with GnRH analogue.
    Utine GE; Alikasifoglu A; Alikasifoglu M; Tuncbilek E
    Eur J Med Genet; 2006; 49(1):79-82. PubMed ID: 16473313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of central precocious puberty.
    Kaplowitz PB
    Curr Opin Endocrinol Diabetes Obes; 2009 Feb; 16(1):31-6. PubMed ID: 19104235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presentation and evolution of organic central precocious puberty according to the type of CNS lesion.
    Trivin C; Couto-Silva AC; Sainte-Rose C; Chemaitilly W; Kalifa C; Doz F; Zerah M; Brauner R
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):239-45. PubMed ID: 16886967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The histrelin implant: a novel treatment for central precocious puberty.
    Hirsch HJ; Gillis D; Strich D; Chertin B; Farkas A; Lindenberg T; Gelber H; Spitz IM
    Pediatrics; 2005 Dec; 116(6):e798-802. PubMed ID: 16322137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precocious puberty in Sanfilippo IIIA disease: diagnosis and follow-up of two new cases.
    Concolino D; Muzzi G; Pisaturo L; Piccirillo A; Di Natale P; Strisciuglio P
    Eur J Med Genet; 2008; 51(5):466-71. PubMed ID: 18586597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial growth deceleration during GnRH analogue therapy for precocious puberty.
    Mouat F; Hofman PL; Jefferies C; Gunn AJ; Cutfield WS
    Clin Endocrinol (Oxf); 2009 May; 70(5):751-6. PubMed ID: 19178517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Final height after combined growth hormone and GnRH analogue treatment in adopted girls with early puberty.
    Tuvemo T; Jonsson B; Gustafsson J; Albertsson-Wikland K; Aronson AS; Häger A; Ivarson S; Kriström B; Marcus C; Nilsson KO; Westgren U; Westphal O; Aman J; Proos LA
    Acta Paediatr; 2004 Nov; 93(11):1456-62. PubMed ID: 15513572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function.
    Heger S; Müller M; Ranke M; Schwarz HP; Waldhauser F; Partsch CJ; Sippell WG
    Mol Cell Endocrinol; 2006 Jul; 254-255():217-20. PubMed ID: 16757104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impact of gonadotropin-releasing hormone analogs treatment on final height in girls with central precocious puberty].
    Chen SK; Fan X; Tang Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 May; 11(5):374-6. PubMed ID: 19470261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid outcome during long-term gonadotropin-releasing hormone agonist treatments for idiopathic precocious puberty.
    Massart F; Harrell JC; Federico G; Saggese G
    J Adolesc Health; 2007 Mar; 40(3):252-7. PubMed ID: 17321426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.